Asina Journal Of Traditional Medicines

Previous Articles     Next Articles

Network pharmacology-based virtual screening of the active ingredients and potential targets from amide alkaloids of Piper genus against Alzheimer’s disease

Weiyu Zhou, Ming Bai, Xiaoxiao Huang*, Shaojiang Song*   

  1. Department of Natural Products Chemistry, Key Laboratory of Structure-Based Drug Design and Discovery, Ministry of Education, School of Traditional Chinese Materia Medica, Shenyang Pharmaceutical University, Shenyang 110016, PR China
  • Received:2017-11-27 Revised:2018-03-18 Online:2018-10-20 Published:2018-11-13
  • Contact: School of Traditional Chinese Materia Medica, Shenyang Pharmaceutical University, 103 Wenhua Rd., Shenyang 110016, China; Tel.: +86-24-23986510 (Xiaoxiao Huang); E-mail: xiaoxiao270@163.com (Xiaoxiao Huang); School of Traditional Chinese Materia Medica, Shenyang Pharmaceutical University, 103 Wenhua Rd., Shenyang 110016, China; Tel.: +86-24-23986510 (Shaojiang Song); E-mail: songsj99@163.com (Shaojiang Song)

Abstract: Alzheimer’s disease (AD) is a genetically complex neurodegenerative disease and its pathological mechanism has not been fully discovered. In the current study, we have examined the medicinal effect of amide alkaloids of the Piper genus in the treatment of AD using network pharmacology. High-confidence level networks consisting of compound-protein target and protein targetpathway association were developed and the potential active amide alkaloids of the Piper genus, the potential target proteins and the key pathways were predicted by network pharmacology models. Overall, this approach provided a novel strategy to explore the role of amide alkaloids of the Piper genus in the treatment of AD from a holistic perspective.

Key words: Alzheimer’s disease, amide alkaloids, Piper genus, network pharmacology